EMAS Position Statements and Clincial Guides
Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Position Statement
Approximately 1.3% of women will be diagnosed with ovarian cancer at some point during their life. Mortality is high, with a 5-year survival rate ranging from 36% to 46%, although there has been a net survival improvement during the last decades, especially among young and mid-aged women [1,2].EMAS position statement: Management of uterine fibroids
Uterine fibroids (also termed leiomyomas or myomas) are the most common tumors of the female reproductive tract.
